Analyst Consensus ?
ConsensusBuy45 ratings
Bullish2657.8%
Neutral1737.8%
Bearish24.4%
FN2 Earnings Intelligence
Anheuser-Busch InBev SA/NV complete analyst coverage
Anheuser-Busch InBev SA/NV (BUD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$79.52Current
$63Low
$79.81Average
$100High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Barclays | Equal Weight | Overweight | Downgrade | Jul 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 13, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | May 12, 2025 |
| Citigroup | Buy | Neutral | Upgrade | Oct 1, 2024 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 12, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 10, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Sep 29, 2023 |
| Deutsche Bank | Buy | Hold | Upgrade | Jun 22, 2023 |
| Redburn Partners | Buy | Neutral | Upgrade | Nov 19, 2021 |
| Argus Research | Hold | Buy | Downgrade | Sep 30, 2021 |
| CFRA | Hold | Hold | Maintain | May 26, 2020 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Mar 12, 2020 |
| Credit Suisse | Neutral | Outperform | Downgrade | Mar 9, 2020 |
| Bryan Garnier | Neutral | Buy | Downgrade | Feb 28, 2020 |
| Redburn | Neutral | Sell | Upgrade | Nov 18, 2019 |
| UBS | Neutral | Buy | Downgrade | Aug 6, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jul 29, 2019 |
| Macquarie | Neutral | Neutral | Maintain | Mar 1, 2019 |
| Argus | Hold | Buy | Downgrade | Nov 12, 2018 |
| HSBC | Buy | Hold | Upgrade | Jun 4, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Mar 12, 2018 |
| Investec | Hold | Buy | Downgrade | Nov 17, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Oct 20, 2016 |
| Kepler Cheuvreux | Buy | Hold | Upgrade | Aug 22, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Aug 1, 2016 |
| Berenberg | Buy | Hold | Upgrade | Nov 13, 2015 |
| CLSA | Outperform | Underperform | Upgrade | Nov 2, 2015 |
| Ingalls & Snyder, LLC | Buy | Hold | Upgrade | Aug 26, 2015 |
| ING | Buy | Hold | Upgrade | Aug 26, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 31, 2015 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2015 |
| Nomura | Neutral | Buy | Downgrade | Jul 21, 2015 |
| Tigress Financial | Underperform | Neutral | Downgrade | Mar 17, 2015 |
| BTIG Research | Neutral | Buy | Downgrade | Sep 9, 2014 |
| BTIG | Neutral | Buy | Downgrade | Sep 9, 2014 |
| Rabobank | Buy | Hold | Upgrade | Jul 31, 2013 |
| Mirabaud Securities | Accumulate | Neutral | Upgrade | Jul 31, 2013 |
| Mirabaud | Accumulate | Neutral | Upgrade | Jul 31, 2013 |
| KBC Partners | Accumulate | Hold | Upgrade | Jul 31, 2013 |
| Canaccord Genuity | Buy | Hold | Upgrade | Jul 31, 2013 |
| Banco Sabadell | Sell | Buy | Downgrade | Apr 30, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $79.52. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Chris Carey | $97 | $86.14 | +22.0% | Jul 31, 2026 |
| Morgan Stanley | Analyst unavailable | $84.5 | $80.25 | +6.3% | Jul 1, 2026 |
| Morgan Stanley | Analyst unavailable | $82 | $74.39 | +3.1% | Apr 8, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $79.4 | +25.8% | Feb 13, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $75.81 | +6.9% | Feb 9, 2026 |
| Wells Fargo | Analyst unavailable | $75 | $61.16 | -5.7% | Nov 19, 2025 |
| Jefferies | Edward Mundy | $74 | $59.85 | -6.9% | Sep 29, 2025 |
| Argus Research | Analyst unavailable | $70 | $62.14 | -12.0% | Mar 27, 2025 |
| Morgan Stanley | Sarah Simon | $63 | $49.22 | -20.8% | Jan 9, 2025 |
| Morgan Stanley | Sarah Simon | $73 | $63.66 | -8.2% | Sep 10, 2024 |
| Morgan Stanley | Sarah Simon | $68.5 | $59.96 | -13.9% | Apr 8, 2024 |
| Barclays | Eddie Kim | $65 | $60.2 | -18.3% | Mar 5, 2024 |
| Jefferies | Edward Mundy | $76 | $66.15 | -4.4% | Jan 10, 2024 |
Track every rating change on BUD the moment it posts. Free to start.
Start freeGet the BUD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.